Pliant Therapeutics, Inc. (PLRX)
USD 14.0
(-2.57%)
USD 14.0
(-2.57%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -116.36 Million | -94.63 Million | -75.44 Million | -37.27 Million | -2.75 Million | -28.32 Million |
| Net Income | -161.33 Million | -123.32 Million | -97.26 Million | -41.53 Million | -631 Thousand | -30.27 Million |
| Depreciation & Amortization | 1.84 Million | 1.82 Million | 1.53 Million | 1.31 Million | 1.11 Million | 666 Thousand |
| Deferred income taxes | -4.95 Million | - | - | - | -12.19 Million | - |
| Stock-based compensation | 44.48 Million | 22.59 Million | 10.43 Million | 3.89 Million | 1.82 Million | 228 Thousand |
| Change in working capital | 1.25 Million | 4.21 Million | 6.91 Million | -1.2 Million | -5.06 Million | 1.05 Million |
| Other non-cash items | 2.35 Million | 52 Thousand | 2.93 Million | 266 Thousand | 12.19 Million | 1.05 Million |
| Investing Cash Flow | -127.01 Million | -150.2 Million | 73.69 Million | -210.86 Million | -17.93 Million | -2.32 Million |
| Investments in PPE | -921 Thousand | -1.76 Million | -1.95 Million | -1.53 Million | -964 Thousand | -2.32 Million |
| Acquisitions | 126.09 Million | 148.44 Million | -75.65 Million | 209.33 Million | 254 Thousand | - |
| Investment purchases | -583.06 Million | -325.71 Million | -219.88 Million | -322.6 Million | -51.96 Million | - |
| Sales/Maturities of investments | 456.97 Million | 177.27 Million | 295.53 Million | 113.27 Million | 35 Million | - |
| Other Investing Activities | -126.09 Million | -148.44 Million | 75.65 Million | -209.33 Million | -254 Thousand | - |
| Financing Cash Flow | 274.4 Million | 226.85 Million | 2.52 Million | 213.21 Million | 45.53 Million | 87.34 Million |
| Debt repayment | - | -10 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 275.25 Million | 217.56 Million | 2.98 Million | 160.75 Million | 48.12 Million | 32 Thousand |
| Other Financing Activities | -847 Thousand | 9.29 Million | -457 Thousand | 52.46 Million | 45.53 Million | 87.31 Million |
| Accounts receivables | 1.98 Million | 15 Thousand | 7.28 Million | -2.22 Million | -7.05 Million | -250 Thousand |
| Accounts payables | 2.96 Million | -1.35 Million | 891 Thousand | 922 Thousand | -1.25 Million | 760 Thousand |
| Inventory | - | - | - | 113 Thousand | 3.19 Million | - |
| Other working capital | -3.7 Million | 5.55 Million | -1.25 Million | -17 Thousand | 50 Thousand | 294 Thousand |
| Cash at beginning of period | 33.68 Million | 51.66 Million | 50.88 Million | 85.8 Million | 60.94 Million | 4.25 Million |
| Cash at end of period | 63.23 Million | 33.68 Million | 51.66 Million | 50.88 Million | 85.8 Million | 60.94 Million |
| Capital Expenditure | -921 Thousand | -1.76 Million | -1.95 Million | -1.53 Million | -964 Thousand | -2.32 Million |
| Effect of forex changes on cash | -1.48 Million | - | - | - | - | - |
| Net cash flow / Change in cash | 29.54 Million | -17.98 Million | 783 Thousand | -34.92 Million | 24.85 Million | 56.69 Million |
| Free Cash Flow | -117.28 Million | -96.39 Million | -77.39 Million | -38.8 Million | -3.71 Million | -30.65 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -55.85 Million | -46.95 Million | -161.33 Million | -41.1 Million | -41.48 Million | -41.19 Million |
| Depreciation & Amortization | 622 Thousand | 513 Thousand | 1.84 Million | 464 Thousand | 448 Thousand | 477 Thousand |
| Deferred income taxes | - | - | -4.95 Million | 7.63 Million | -3.7 Million | -3.92 Million |
| Stock-based compensation | 10.64 Million | 9.66 Million | 44.48 Million | 9.15 Million | 10.36 Million | 13.04 Million |
| Change in working capital | -1.71 Million | 4.73 Million | 1.25 Million | 609 Thousand | -2.44 Million | 6.21 Million |
| Other non-cash items | 16.51 Million | 10.2 Million | 2.35 Million | -1.84 Million | 597 Thousand | 627 Thousand |
| Investing Cash Flow | 10.7 Million | 59.54 Million | -127.01 Million | 31.92 Million | 38.25 Million | -22.97 Million |
| Investments in PPE | -1.25 Million | -1.49 Million | -921 Thousand | -61 Thousand | -94 Thousand | -603 Thousand |
| Acquisitions | - | - | 126.09 Million | -158.07 Million | -38.34 Million | 22.37 Million |
| Investment purchases | -48.52 Million | -52.37 Million | -583.06 Million | -57.49 Million | -114.47 Million | -134.47 Million |
| Sales/Maturities of investments | 60.47 Million | 113.41 Million | 456.97 Million | 89.47 Million | 152.82 Million | 112.1 Million |
| Other Investing Activities | 11.95 Million | 61.03 Million | -126.09 Million | 158.07 Million | 38.34 Million | -22.37 Million |
| Financing Cash Flow | 684 Thousand | 21.78 Million | 274.4 Million | 219 Thousand | 699 Thousand | 161 Thousand |
| Debt repayment | - | -19.9 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 684 Thousand | 1.87 Million | 275.25 Million | 232 Thousand | 4.76 Million | 161 Thousand |
| Other Financing Activities | 684 Thousand | 1.87 Million | -847 Thousand | -13 Thousand | -75 Thousand | -173 Thousand |
| Accounts receivables | - | - | 1.98 Million | - | 1.58 Million | 1.71 Million |
| Accounts payables | -3.62 Million | 2.25 Million | 2.96 Million | 1.17 Million | 1.05 Million | 882 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.91 Million | 2.47 Million | -3.7 Million | -563 Thousand | -5.08 Million | 3.61 Million |
| Cash at beginning of period | 114.29 Million | 63.23 Million | 33.68 Million | 57.67 Million | 54.95 Million | 102.52 Million |
| Cash at end of period | 80.38 Million | 114.29 Million | 63.23 Million | 63.23 Million | 57.67 Million | 54.95 Million |
| Capital Expenditure | -1.25 Million | -1.49 Million | -921 Thousand | -61 Thousand | -94 Thousand | -603 Thousand |
| Effect of forex changes on cash | - | - | -1.48 Million | 1.36 Million | -1.36 Million | - |
| Net cash flow / Change in cash | -33.91 Million | 51.06 Million | 29.54 Million | 5.55 Million | 2.72 Million | -47.57 Million |
| Free Cash Flow | -46.54 Million | -31.76 Million | -117.28 Million | -25.16 Million | -36.31 Million | -25.36 Million |
2929
BERY
0HGV
NICE
HLI
600438